These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18290317)

  • 1. Activated protein C modulates chemokine response and tissue injury in experimental sepsis.
    Sharma GR; Gerlitz B; Berg DT; Cramer MS; Jakubowski JA; Galbreath EJ; Heuer JG; Grinnell BW
    Adv Exp Med Biol; 2008; 614():83-91. PubMed ID: 18290317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response.
    Richardson MA; Gupta A; O'Brien LA; Berg DT; Gerlitz B; Syed S; Sharma GR; Cramer MS; Heuer JG; Galbreath EJ; Grinnell BW
    J Pharmacol Exp Ther; 2008 Apr; 325(1):17-26. PubMed ID: 18182560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protein C in renal dysfunction after polymicrobial sepsis.
    Gupta A; Berg DT; Gerlitz B; Sharma GR; Syed S; Richardson MA; Sandusky G; Heuer JG; Galbreath EJ; Grinnell BW
    J Am Soc Nephrol; 2007 Mar; 18(3):860-7. PubMed ID: 17301189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C versus protein C in severe sepsis.
    Yan SB; Dhainaut JF
    Crit Care Med; 2001 Jul; 29(7 Suppl):S69-74. PubMed ID: 11445737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C in critical illness.
    Mann HJ; Short MA; Schlichting DE
    Am J Health Syst Pharm; 2009 Jun; 66(12):1089-96. PubMed ID: 19498123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of human protein C improves survival in an experimental model of sepsis.
    Messaris E; Betrosian AP; Memos N; Chatzigianni E; Boutsikou M; Economou V; Dontas I; Theodossiades G; Konstadoulakis MM; Douzinas EE
    Crit Care Med; 2010 Jan; 38(1):209-16. PubMed ID: 19726977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsis.
    Berg DT; Gerlitz B; Sharma GR; Richardson MA; Stephens EJ; Grubbs RL; Holmes KC; Fynboe K; Montani D; Cramer MS; Engle SD; Jakubowski JA; Heuer JG; Grinnell BW
    Clin Vaccine Immunol; 2006 Mar; 13(3):426-32. PubMed ID: 16522789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C alters inflammation and protects renal function in sepsis.
    Keller SA; Moore CC; Evans SL; McKillop IH; Huynh T
    J Surg Res; 2011 Jun; 168(1):e103-9. PubMed ID: 21429520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Activated Protein C on Attenuation of Ischemia-Reperfusion Injury in a Rat Muscle Flap Model.
    Zhang EW; Fang T; Arnold PB; Songcharoen SJ; Lineaweaver WC; Zhang F
    Ann Plast Surg; 2015 Oct; 75(4):448-54. PubMed ID: 26360654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression following activated protein C treatment during septic shock.
    Moore CC; McKillop IH; Huynh T
    J Surg Res; 2013 Jun; 182(1):116-26. PubMed ID: 22940033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of heparin and allied compounds in the treatment of sepsis.
    Cornet AD; Smit EG; Beishuizen A; Groeneveld AB
    Thromb Haemost; 2007 Sep; 98(3):579-86. PubMed ID: 17849046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
    Coquerel D; Neviere R; Delile E; Mulder P; Marechal X; Montaigne D; Renet S; Remy-Jouet I; Gomez E; Henry JP; do Rego JC; Richard V; Tamion F
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1032-44. PubMed ID: 24578383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C and sepsis.
    O'Brien LA; Gupta A; Grinnell BW
    Front Biosci; 2006 Jan; 11():676-98. PubMed ID: 16146761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein C pathway and sepsis.
    Della Valle P; Pavani G; D'Angelo A
    Thromb Res; 2012 Mar; 129(3):296-300. PubMed ID: 22154246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human activated protein C for the treatment of severe sepsis: is there a role in pediatrics?
    Giroir BP
    Curr Opin Pediatr; 2003 Feb; 15(1):92-6. PubMed ID: 12544278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits after systemic induction of inducible nitric oxide synthase: a randomised trial in rats.
    Eckel B; Ohl F; Bogdanski R; Kochs EF; Blobner M
    Eur J Anaesthesiol; 2011 Sep; 28(9):655-63. PubMed ID: 21743335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis.
    Jia YX; Pan CS; Yang JH; Liu XH; Yuan WJ; Zhao J; Tang CS; Qi YF
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1202-8. PubMed ID: 17184502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of protein C concentrate in pediatric patients with sepsis.
    Silvani P; Camporesi A; Licari E; Wolfler A
    Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction induced by activated protein C: no role in protection against sepsis?
    Slofstra SH; ten Cate H; Spek CA
    Trends Mol Med; 2006 Aug; 12(8):374-81. PubMed ID: 16820322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.